TRGP NYSE Week ended 24 Jul 2026

Weekly Investor Report

Targa Resources Inc · Energy · Oil & Gas Midstream

Latest close 281.3 USD
-0.6% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 16.9% above the Trend Line and sits at 93.5% of its 52-week range. The latest completed week returned -0.6%, after a 3.2% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is expensive relative to peers. Options positioning is bullish with 46/100 conviction, while the latest news-sentiment score is 52/100. Near-term considerations: price is close to its 52-week high; volume confirmation is below normal; earnings are due in 5d.

Setup score 69 out of 100
Latest Close 281.3 USD 24 Jul 2026
1W Return -0.6% latest completed week
4W Return 3.2% short-term follow-through
12W Return 10.6% quarterly tape
Trend Breadth 65.4% 34 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
What is working
  • The trend backdrop is active with a 34-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Next-week expectancy is positive at 62.38% based on similar historical setup states.
What could go wrong
  • Activity pressure is negative, which weakens the current setup.
  • 17 reversal markers appear in the recent smart-money tape.
  • Latest weekly return ranks in the weaker part of its sector group.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 16.9% above the Trend Line and sits at 93.5% of its 52-week range. The latest completed week returned -0.6%, after a 3.2% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9712-week average 0.97

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.97Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers1717 reversal markers

No recent accumulation markers. 17 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 3.2% over four weeks, 10.6% over 12 weeks, and 73.7% over one year. The current trend has remained active for 34 consecutive weeks.

Performance by holding period

1W-0.6%
4W3.2%
12W10.6%
26W48.3%
52W73.7%
Active trend streak34 weeks
Active weeks in one year34
Trend breadth65.4%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.07Latest activity-pressure read.
Pressure change24.9%Four-week change in activity pressure.
Leadership25.68Latest relative-leadership reading.
RS change-3.6%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 100% Model confidence 96%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength52/100Blend of value, momentum, and quality. Underlying universe rank 49; rank 1 is best.
Value11/100Relative valuation strength. Underlying universe rank 90; rank 1 is best.
Quality87/100Profitability and accounting quality. Underlying universe rank 14; rank 1 is best.
Momentum91/100Medium-term price momentum. Underlying universe rank 10; rank 1 is best.
Growth67/100Revenue and earnings growth. Underlying universe rank 34; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework29/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
28.4x
Price divided by trailing earnings.
Price / sales
3.7x
Market value relative to trailing revenue.
EV / EBITDA
16.0x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
9.0%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
29.9%
Gross profit retained from each unit of revenue.
Operating margin
20.8%
Operating profit retained from revenue.
Free-cash-flow margin
43.6%
Free cash flow generated from revenue.
Return on invested capital
12.1%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-2.3%
Latest one-year revenue growth.
EPS growth
72.7%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
4.8%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
1.5%
Cash dividends relative to market value.
Buyback yield
0.9%
Net share repurchases relative to market value.
Shareholder yield
2.5%
Dividend yield plus net buyback yield.
Net debt / EBITDA
3.8x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

TRGP shows bullish options pressure with a 46/100 conviction score, put-call volume ratio of 0.54, expected move of 7.6%, and Sharemaestro trend signal active.

Conviction46/100
Expected move7.6%
Put/call volume0.54
Pressure40
Speculation36
Volatility55
Trend agreement63
Open options detail
Insider activity1 / 3

1 acquisitions and 3 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment52/100

Weighted news tone is neutral across 57 relevant articles.

18 positive · 31 neutral · 8 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings5dNext report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
Options expected move7.6%Nearest-chain priced movement where available.
52-week drawdown-3.3%Distance below the 52-week high.
13-week volatility5.0%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher17 of 269 weeks finished lower.
Best week+9.6%Week of 15 May.
Worst week-7.8%Week of 29 May.
Latest week-0.6%Week of 24 Jul.

Shape of recent returns

Strong gains8
Modest gains9
Flat weeks0
Modest losses6
Sharp losses3
Recent vol5.0%13-week weekly-return volatility.
Base vol4.0%52-week weekly-return volatility.
Up/down split33/19Count of positive and negative weeks in the 52-week window.
Average skew3.6% / -3.1%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 2026281.3 USD-0.6%240.7 USD157.7 USD-0.0725.685.1MOn
17 Jul 2026282.9 USD3.5%237.4 USD156.3 USD-0.0126.645.7MOn
10 Jul 2026273.4 USD5.6%233.8 USD155.0 USD-0.1621.334.9MOn
3 Jul 2026258.9 USD-5.0%230.8 USD153.7 USD-0.0917.157.2MOn
26 Jun 2026272.6 USD5.4%228.1 USD152.5 USD-0.1026.647.2MOn
19 Jun 2026258.6 USD-5.1%224.8 USD151.2 USD-0.2717.996.0MOn
12 Jun 2026272.6 USD3.2%221.8 USD150.0 USD-0.0526.054.6MOn
5 Jun 2026264.1 USD3.5%218.5 USD148.7 USD0.1323.454.8MOn
29 May 2026255.1 USD-7.8%215.3 USD147.4 USD0.2316.885.6MOn
22 May 2026276.8 USD1.8%211.9 USD146.2 USD0.4829.285.4MOn
15 May 2026272.0 USD9.6%207.7 USD144.8 USD0.4329.016.5MOn
8 May 2026248.1 USD-2.4%203.5 USD143.5 USD0.4218.676.5MOn
1 May 2026254.3 USD6.2%200.3 USD142.4 USD0.6424.966.3MOn
24 Apr 2026239.5 USD2.2%197.1 USD141.2 USD0.8519.405.4MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.